4 ms·
> The FDA approved the first generic auto-injector in 2018. Sure, but the length of the time it took, plus the lack of any pressure on the price of name-brand
by quacked 2y ago
> The FDA approved the first generic auto-injector in 2018.
Sure, but the length of the time it took, plus the lack of any pressure on the price of name-brand EpiPens, is a huge problem, in my view. The legal barriers to market entry should be exclusively technical (i.e. can you prove that your process meets consequential technical standards), and right now they're quite removed from that.